IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia

Background  Treatment for neonatal alloimmune thrombocytopenia (NAIT) primarily involves maternal administration of intravenous immunoglobulin (IVIG) therapy and prednisone according to protocols based on risk stratification. While IVIG is generally well tolerated, hematologic side effects are a pot...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrmann, Alyssa, Samelson-Jones, Benjamin J., Brake, Sami, Samelson, Renee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621970/
https://www.ncbi.nlm.nih.gov/pubmed/28970962
http://dx.doi.org/10.1055/s-0037-1607055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621970/
https://www.ncbi.nlm.nih.gov/pubmed/28970962
http://dx.doi.org/10.1055/s-0037-1607055

Ejemplares similares